Are another 5 yearsof adjuvant aromatase inhibitor therapy needed?

Breast Cancer: Targets and Therapy

关键词: breast cancer;    adjuvant endocrine therapy;   

DOI  :  

来源: DOAJ

【 摘 要 】

Qin-Guo Mo*, De-Quan Li*, Jian-Hong Zhong, Chang-Yuan Wei Department of Breast Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People’s Republic of China *These authors contributed equally to this workIn the recent issue of Breast Cancer: Targets and Therapy, some questions about adjuvant systemic therapy1 and bone loss and skeletal-related events in postmenopausal women with hormone receptor-positive breast cancer2 were discussed by two reviews.View original paper by Leone and colleagues.

【 授权许可】

Unknown